piboserod has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, L; Bhattacharyya, S; Korkutata, M; Shiga, T; Vimal, SK; Yadav, MK | 1 |
| Claeysen, S; Dallemagne, P; Lanthier, C; Lecoutey, C; Rochais, C | 1 |
2 review(s) available for piboserod and Cholera Infantum
| Article | Year |
|---|---|
Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut.
Topics: Animals; Brain; Comorbidity; Depression; Gastrointestinal Diseases; Gastrointestinal Microbiome; Humans; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists | 2020 |
Therapeutic modulators of the serotonin 5-HT
Topics: Animals; Central Nervous System Diseases; Drug Development; Gastrointestinal Diseases; Humans; Ligands; Patents as Topic; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists | 2020 |